You can buy or sell ContraFect and other stocks, options, ETFs, and crypto commission-free!
ContraFect Corp. engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza. Read More The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
Yonkers, New York
52 Week High
52 Week Low
Markets InsiderMar 13
ContraFect to Present at the Oppenheimer 29th Annual Healthcare Conference
YONKERS, New York, March 13, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of novel, differentiated biologic therapeutics for life-threatening, drug-resistant infectious diseases, today announced that Steven C. Gilman, Ph.D., the Company's Chairman and Chief Executive Officer, will participate in the 29th Annual Oppenheimer Healthcare Conference on Wednesday, March 20, 2019, at 3:55 PM ET in New York City.
Stock Price, News, & Analysis for ContraFect
ContraFect Corporation, a clinical-stage biotechnology company, focuses on discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases in the United States.
Guru FocusFeb 25
Glancy Prongay & Murray LLP Continues Investigation on Behalf of ContraFect Corporation Investors (CFRX)
LOS ANGELES, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of ContraFect Corporation ( CFRX) investors concerning the Company and its directors’ and officers’ possible violations of state laws. If you purchased ContraFect stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, of GPM, 1925 Century Park East, Su...
-$0.10 per share
-$0.08 per share